All G Foods’ mission is to feed the earth in a responsible, environmentally friendly, nutritious and delicious way. The Buds brand focuses on plant-based meat and dairy, and The Casein Project focuses on the precision fermentation of dairy proteins for the production of animal free milk and dairy products.

This partnership will undertake vital research to build the next generation of alternative proteins produced by precision fermentation.

A Californian company delivering high-performance alternatives to petroleum, plant – and animal-based products, Amyris focuses on engineering new yeast strains and chemicals using innovative tools such as its Automated Strain Engineering platform.

This partnership is exploring future directions in advanced biomanufacturing.

Bioplatforms Australia (BPA) provides world-class research capabilities and infrastructure in omics and will be providing priority access to CoESB researchers. The CoESB has launched a funding scheme in collaboration with BPA to support omics testing at its 15 facilities of synthetic constructs or organisms built by CoESB researchers.

With the CoESB, Bondi Bio is aiming to engineer cyanobacteria that grow on carbon dioxide and sunlight for the production of valuable chemicals. One of the first targets is a synthetic squalene, an emollient in skincare and an adjuvant for mRNA vaccines currently sourced from shark fins.

Calysta is a biotechnology company based in California, USA, focused on the conversion of methane to high-value products via its proprietary bioconversion platform. An innovator of sustainable products to improve food security, Calysta seeks the Centre’s input on new opportunities it has identified in Australia for commercial feedstock utilisation.

The Department of Primary Industries (DPI) is responsible for driving economic growth within its portfolio across NSW and sees the application of synthetic biology underpinning the innovations necessary to withstand future challenges. They include solutions for pest control, nutrient accessibility for crops, biosensors and feed assimilation.

As part of this partnership DPI funds a postdoctoral research fellow within the CoESB.

East West provides significant investment in synthetic biology ventures, from seed funding to early start up. With an interest in Australia’s emerging bioeconomy, CEO
Gordon Black advises on aspects of commercialisation while providing a conduit to the wider community on entrepreneurial opportunities.

Hunter Biological Solutions is a consultancy focused on providing expertise in microbiology, biochemistry and synthetic biology. The company was founded in 2022 by Prof Peter Lewis and is involved with several CoESB groups and projects, including the Ethtec Hunter Pilot Biorefinery plant construction and open access operation, and Wild Yeast Zoo.

A global leader in gas fermentation, LanzaTech is exploring the Centre’s capabilities in systems bioengineering to support new and existing Clostridial strains for sustainable fuels and chemicals and removing bottlenecks in production.

Manildra Group is Australia’s largest producer of bioethanol and is looking for CoESB researchers to develop microbes that can use fermentation by‑products to create new bioplastics.

A biotechnology company based in Brisbane, Microba is focused on human gut microbiomes. It is helping the CoESB in analysing microbiome data to isolate genomes from microbial communities and understanding how to grow these microorganisms together as a synthetic community.

A biotechnology company focused on screening microbial diversity for natural product delivery, Microbial Screening Technologies is keen to explore with the CoESB the development of novel biomolecules for commercial applications.

Neochromosome is a start-up company based in New York City, with a mission to apply world-leading and disruptive chromosome synthesis and engineering technologies for expression of commercially valuable biological pathways in eukaryotic cells.

As a world leader in the field of genome writing, Neochromosome is exploring collaborative opportunities with the CoESB in synthetic microbial communities, synthetic organelles and neobiochemistry.

No8 Bio pioneers transformative change in the AgriTech and CleanTech sectors, providing innovative and sustainable methods to reduce livestock emissions. Its product BetterFeed can achieve a reduction in methane of up to 80% and an increase in digestive efficiency.

Key recent milestones include the commencement of first cattle trials and the active construction of a pilot plant in Lane Cove, emphasising scalability.

Nourish specialises in using microbial fermentation to produce animal- free better-than-alternative oils and fats to improve plantbased proteins for human consumption. Nourish strives to provide specialised ingredients for sustainable food solutions using cutting-edge technologies, including synthetic biology, to achieve this goal. Partnership with the CoESB gives Nourish access to world-class leaders in synthetic biology, with CoESB partners benefiting from Nourish’s industrial R&D and fermentation upscaling experience.

The Australian Wine Research Institute, one of the world’s leading grape and wine research and development organisations, is partnering with the CoESB to explore synthetic biology technologies, particularly in the development of new yeast and bacteria involved in primary and secondary fermentation of grapes and production of premium wine.

Twist is an innovative and dynamic Californian biotech company aiming to power the new global bio-based economy through the manufacture and supply of synthetic DNA and biomaterials.

The Centre’s research on Synthetic Organelles & Neobiochemistry closely aligns with Twist’s mission to enable the generation and development of novel biology based products for a more sustainable and ecofriendly future.

Scion, a government-owned Crown Research Institute based in Rotorua, New Zealand, specialises in research and science and technology development for the forestry, wood products, wood-derived materials and other biomaterial sectors.

Scion is developing a suite of capabilities with the CoESB based on feedstock utilisation, pathway engineering and biopolymer production.

The Centre de Recerca en Agrigenòmica CSICIRTA-UAB-UB (CRAG) is an independent Spanish research institution with expertise in plant molecular biology, biotechnology, genetics and genomics. It aims to use biotechnology to increase the production of isoprenoids and carotenoids in plants, research which complements the CoESB’s work in building synthetic chloroplasts in yeast and engineering isoprenoid pathways.

As Australia’s national science agency, CSIRO has recognised the importance of synthetic biology by investing in the Synthetic Biology Future Science Platform to create new industries for Australia. It is collaborating with the CoESB on a range of projects across science and social sciences.

Imperial College London hosts the largest cluster of synthetic biology teams at any one site in Europe. Building on research relationships built through the Yeast 2.0 Project, this partnership will openly share pre-competitive biological tools, software and strains.

The National University of Singapore has a strong pedigree in visionary enterprise. The University has identified specific commercial applications for product development in Australia which will benefit from the involvement of CoESB researchers.

The Institute of Synthetic Biology (iSynBio) within the Shenzhen Institute of Advanced Technology focuses on the reconstruction of artificial life components, gene circuits, biological sciences and multicellular systems to decipher the essence of life. As such, it is keen on collaborating on CoESB research within the synthetic communities, synthetic organelles and neobiochemistry themes.

The UK Centre for Mammalian Biology, housed at the University of Edinburgh, will be sharing protocols, software and practices with the CoESB, particularly in the areas of metabolic engineering, genome editing and the social dimensions of this powerful science.

The University of York’s Department of Biology is the strength behind the BioYork Initiative which aims to drive the development of bio-based industries. Its alignment with CoESB research is in using synthetic biology to engineer transporters and cell membranes.

Industrial biotechnology is one of the key priorities of the UK’s University of Manchester and its SYNBIOCHEM Centre. Building on existing collaborations formed through the Yeast 2.0 Project, this partnership explores collaborative possibilities with the CoESB in engineering biosynthetic routes to fine and speciality chemicals.

Based in Israel, the Weizmann Institute of Science specialises in protein design. It is contributing to joint research aimed at developing new protein components and automated methods for designing such proteins.